Literature DB >> 12146796

Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice.

Oliver Wirths1, Gerd Multhaup, Christian Czech, Nicole Feldmann, Véronique Blanchard, Günter Tremp, Konrad Beyreuther, Laurent Pradier, Thomas A Bayer.   

Abstract

Neuropil deposition of beta-amyloid peptides A beta40 and A beta42 is believed to be the key event in the neurodegenerative processes of Alzheimer's disease (AD). Since A beta seems to carry a transport signal that is required for axonal sorting of its precursor beta-amyloid precursor protein (APP), we studied the intraneuronal staining profile of A beta peptides in a transgenic mouse model expressing human mutant APP751 (KM670/671NL and V7171) and human mutant presenilin-1 (PS-1 M146L) in neurons. Using surface plasmon resonance we analyzed the A beta antibodies and defined their binding profile to APP, A beta40 and A beta42. Immunohistochemical staining revealed that intraneuronal A beta40 and A beta42 staining preceded plaque deposition, which started at 3 months of age. A beta was observed in the somatodendritic and axonal compartments of many neurons. Interestingly, the striatum, which lacks transgenic APP expression harbored many plaques at 10 months of age. This is most likely due to an APP/A beta transport problem and may be a model region to study APP/A beta trafficking as an early pathological event.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12146796     DOI: 10.1111/j.1750-3639.2002.tb00442.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  42 in total

1.  Immersion autometallographic demonstration of pathological zinc accumulation in human acute neural diseases.

Authors:  Lin Zhu; Yong Tang; Han-Dong Wang; Zhi-Yuan Zhang; Hao Pan
Journal:  Neurol Sci       Date:  2011-11-11       Impact factor: 3.307

2.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

Authors:  Caty Casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesús Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 3.  Alzheimer's in 3D culture: challenges and perspectives.

Authors:  Carla D'Avanzo; Jenna Aronson; Young Hye Kim; Se Hoon Choi; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Bioessays       Date:  2015-08-07       Impact factor: 4.345

Review 4.  Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission.

Authors:  Anand Kant Das; Rucha Pandit; Sudipta Maiti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

5.  Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice.

Authors:  Melanie Hüttenrauch; Susanne Walter; Margie Kaufmann; Sascha Weggen; Oliver Wirths
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

Review 6.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

7.  Intracellular accumulation of amyloid-Beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease.

Authors:  Thomas A Bayer; Oliver Wirths
Journal:  Front Aging Neurosci       Date:  2010-03-10       Impact factor: 5.750

8.  Accumulation of intraneuronal Abeta correlates with ApoE4 genotype.

Authors:  Ditte Z Christensen; Thomas Schneider-Axmann; Paul J Lucassen; Thomas A Bayer; Oliver Wirths
Journal:  Acta Neuropathol       Date:  2010-03-10       Impact factor: 17.088

9.  Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.

Authors:  Oliver Wirths; Tobias Bethge; Andrea Marcello; Anja Harmeier; Sadim Jawhar; Paul J Lucassen; Gerd Multhaup; David L Brody; Thomas Esparza; Martin Ingelsson; Hannu Kalimo; Lars Lannfelt; Thomas A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2009-10-13       Impact factor: 3.575

10.  Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model.

Authors:  Oliver Wirths; Henning Breyhan; Holger Cynis; Stephan Schilling; Hans-Ulrich Demuth; Thomas A Bayer
Journal:  Acta Neuropathol       Date:  2009-06-23       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.